Reply to "Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era"

J Allergy Clin Immunol Pract. 2021 Sep;9(9):3531-3532. doi: 10.1016/j.jaip.2021.06.048. Epub 2021 Jul 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Asthmatic Agents*
  • Antibodies, Monoclonal, Humanized
  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • benralizumab